HIV-positive young men who are being treated for the disorder appear to be at greater risk than other men their age of low bone mass, U.S. researchers said. Study co-author Dr. Bill G. Kapogiannis of the Eunice Kennedy Shriver National Institute of Child Health and Human Development said the young men in the study did not have HIV at birth and had been diagnosed an average of two years before the start of the study. Earlier studies have shown adults with HIV also have bone loss and increased risk for bone fractures, associated in part with the use of certain anti-HIV medications, Kapogiannis said. "The young men in the study had been taking anti-HIV medications for a comparatively short time, yet they still had lower bone mineral density than other men their age," Kapogiannis said in a statement. "These findings suggest a short-term impact of HIV therapy on bone at ages when people are still growing and building bone mass. This raises concern about the risk of fracture as they age." Kapogiannis and colleagues found bone density for HIV-infected young men was 5 percent to 8 percent lower in the hip, and 2 percent to 4 percent lower in the spine, than for study participants without HIV. The researchers recommend these patients be monitored, advised to exercise and take vitamin D to prevent future fracture risk. The findings were published the journal Clinical Infectious Diseases.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor